Detalhe da pesquisa
1.
Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.
Gynecol Oncol
; 183: 1-6, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460222
2.
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
Am J Obstet Gynecol
; 2024 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621481
3.
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
Gynecol Oncol
; 173: 106-113, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116391
4.
Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.
Gynecol Oncol
; 177: 72-85, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651980
5.
Cervical Cancer-Related Knowledge, Attitudes, Practices and Self-Screening Acceptance Among Patients, Employees, and Social Media Followers of Major Brazilian Hospital.
Cancer Control
; 29: 10732748221135441, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433760
6.
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Fam Cancer
; 23(2): 111-120, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530571
7.
Developing a Nomogram for Prioritizing Hysteroscopy in Endometrial Cancer Diagnosis: A Case-Control Study.
J Clin Med
; 13(4)2024 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398458
8.
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.
JCO Clin Cancer Inform
; 7: e2300123, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934933